Immunisation provider information and resources

Rotarix® to replace RotaTeq® from 1 July 2017

From 1 July 2017, the oral rotavirus vaccine Rotarix® (2-dose schedule) will replace RotaTeq® (3-dose schedule) across Australia including Western Australia. Children commencing their childhood schedule after 1 July 2017 should receive the Rotarix® brand under the National Immunisation Program (NIP).

Rationale for the change

This will provide consistency across the NIP, including for children moving from one state to another during the course of immunisation. It is important to note that the rotavirus vaccine schedule is not included in the definition of fully vaccinated in relation to eligibility for Commonwealth family assistance payments.

Differences between brands

Rotarix® is administered at 2 months (from 6 weeks) and 4 months of age. It is a 2 dose schedule. RotaTeq® is a 3 dose schedule. Both vaccines are administered orally.

Which vaccine to use?

Providers are encouraged to use the ‘start with, stay with’ principle when deciding which brand of vaccine to administer. Administer the same brand as the child has previously received as per the schedule shown in Table 4.17.1 of The Australian Immunisation Handbook (external site).

Rotavirus vaccine brand to administer from 1 July 2017

Scenario Action Notes
No previous rotavirus vaccine received
Administer 2 doses of Rotarix® as per schedule
1 dose of RotaTeq® brand vaccine received
Administer 2 more doses of RotaTeq® as per schedule
If no RotaTeq® brand vaccine in stock, see ATAGI statement (external site) for dosing and upper age limits of Rotarix® brand vaccine.
2 doses of RotaTeq® brand vaccine received
Administer last dose of RotaTeq® as per schedule
If no RotaTeq® brand vaccine in stock, see ATAGI statement (external site) for dosing and upper age limits of Rotarix® brand vaccine.

Vaccine ordering

Rotarix® is available to order now through the WA Health online ordering system (external site).

RotaTeq® brand vaccine will continue to be available for order after 1 July 2017 to assist you in completing schedules for children who started on RotaTeq®.

Rotavirus vaccine brand transition video:

GSK has developed a video for immunisation providers with information on Rotarix and the ATAGI advice on transitioning from RotaTeq to Rotarix.  To view the video, please visit www.health.gsk.com.au (external site), register and click on Products/Rotarix/Clinical Resources.

Note: Please be reminded that WA providers are encouraged to use the ‘start with, stay with’ principle when deciding which brand of vaccine to administer. Administer the same brand as the child has previously received as per the schedule shown in Table 4.17.1 of The Australian Immunisation Handbook (external site).

GSK resources available for order

The below GSK Support materials are available for order by calling (03) 9413 7665:

  • brochure for health care providers
  • information statement from the Australian Technical Advisory Group on Immunisation
  • Rotarix® administration card
  • parent information
  • Rotarix® dosing wheel.
Vaccine update email list

Vaccine Updates gives immunisation providers important news and information updates about immunisation programs and vaccines in Western Australia.

All immunisation providers are encouraged to sign up to Vaccine Updates.

Structured Administration and Supply Arrangements (SASA)

The CEO of Health has issued the below SASAs to authorise certain Registered Nurses and Midwives to administer vaccines in accordance with the Poisons Regulation 2016. Providers who are eligible to work under the relevant SASA are encouraged to familiarise themselves with the requirements.

Reporting of school program vaccines administered in general practice

From September 2016, vaccines administered throughout the lifespan need to be reported to the whole of life register the Australian Immunisation Register (AIR).

Government-funded vaccines provided for the Year 8 program need to be reported also, to the WA school-based database. Please complete the Report of school program vaccines administered in general practice form (PDF 328KB) for this purpose.

Common reactions from vaccine

Useful information following vaccination was developed for consumers, and parents/guardians of children, when they receive vaccination.

This page explains common reactions following vaccination.

The information is also available as a PDF, Useful information following vaccination (PDF 190KB).

Consent process

The consent process for vaccination enables a parent to make an informed decision regarding vaccination.

If a parent decides not to immunise their child, the points provided on the partial consent can be used to discuss their decision.

Immunisation resources

Immunisation resources to support your practice are available for order on the publication ordering system (external site). Find out how to place an order (PDF 768KB).

Further resources

Produced by

Public Health